0.58
price up icon1.72%   0.0098
after-market Handel nachbörslich: .58
loading
Schlusskurs vom Vortag:
$0.5702
Offen:
$0.5702
24-Stunden-Volumen:
12,273
Relative Volume:
0.14
Marktkapitalisierung:
$3.49M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.0798
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
-3.33%
1M Leistung:
-4.92%
6M Leistung:
+5.26%
1J Leistung:
-78.48%
1-Tages-Spanne:
Value
$0.5702
$0.5872
1-Wochen-Bereich:
Value
$0.5601
$0.61
52-Wochen-Spanne:
Value
$0.3611
$9.079

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Firmenname
Novabay Pharmaceuticals Inc
Name
Telefon
510-899-8800
Name
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Mitarbeiter
86
Name
Twitter
@NovaBayPharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
NBY's Discussions on Twitter

Vergleichen Sie NBY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
0.58 3.49M 14.64M -13.74M -5.04M -7.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-09-18 Eingeleitet Ladenburg Thalmann Buy
2018-07-06 Bestätigt H.C. Wainwright Buy
2017-11-15 Bestätigt Laidlaw Buy
2017-06-05 Eingeleitet ROTH Capital Buy
2017-03-27 Eingeleitet Laidlaw Buy
2017-02-06 Eingeleitet Rodman & Renshaw Buy
2016-03-07 Herabstufung Maxim Group Buy → Hold
2015-12-14 Bestätigt Maxim Group Buy
2015-04-30 Fortgesetzt Maxim Group Buy
2013-03-06 Eingeleitet Ascendiant Capital Markets Strong Buy
2008-01-03 Eingeleitet Dawson James Speculative Buy
Alle ansehen

Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten

pulisher
Apr 26, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 22, 2025

NovaBay Pharmaceuticals approves liquidation plan By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 22, 2025

NovaBay Pharmaceuticals approves liquidation plan - Investing.com

Apr 22, 2025
pulisher
Apr 16, 2025

Poplar Point Capital Partners acquires $39,503 in NovaBay shares - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

Poplar Point Capital Partners increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 15, 2025

Massive Stock Acquisition: Poplar Point Capital Partners Bets Big on NovaBay Pharma! - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $29,857 in NovaBay shares - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $39,503 in NovaBay shares By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $29,857 in NovaBay shares By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 15, 2025

Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions By Investing.com - Investing.com UK

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital increases stake in NovaBay Pharmaceuticals - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

NovaBay Pharmaceuticals sees $67,700 stock acquisition by Poplar Point Capital - Investing.com India

Apr 15, 2025
pulisher
Apr 02, 2025

NovaBay Pharmaceuticals Inc. (NBY) reports earnings - qz.com

Apr 02, 2025
pulisher
Apr 01, 2025

NovaBay Pharmaceuticals Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 28, 2025

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

Revolutionizing Healing: Trends in the Advanced Wound Care Market with NovaBay, Healthy.io - openPR.com

Mar 27, 2025
pulisher
Mar 24, 2025

Blepharitis Treatment Market Future Business Opportunities - openPR.com

Mar 24, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 12, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above 50-Day Moving Average – Time to Sell? - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

NovaBay reaches settlements over disputed warrants By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

NovaBay reaches settlements over disputed warrants - Investing.com India

Mar 11, 2025
pulisher
Mar 08, 2025

NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 07, 2025

Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire

Mar 07, 2025
pulisher
Mar 06, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

NovaBay's Avenova Highlighted in National Dry Eye Awareness Month - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 21, 2025
pulisher
Feb 17, 2025

NovaBay extends CEO's contract through 2025 - MSN

Feb 17, 2025
pulisher
Feb 13, 2025

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Feb 13, 2025
pulisher
Feb 08, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell? - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

NovaBay fails to gain shareholder approval for dissolution - MSN

Feb 06, 2025
pulisher
Feb 04, 2025

NovaBay fails to gain shareholder approval for dissolution By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Jan 28, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World

Jan 28, 2025
pulisher
Jan 25, 2025

**NovaBay Pharmaceuticals Completes Asset Sale Transaction and Plans for Dissolution**** - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

NovaBay Pharmaceuticals Completes the Sale of its Avenova Eyecare Business to PRN, Seeks Full Company Dissolution - Vision Monday

Jan 24, 2025
pulisher
Jan 23, 2025

NovaBay Pharma’s Strategic Shift and Liquidation Plans - TipRanks

Jan 23, 2025

Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):